Old And Impossible Blood Mystery Solved

“After many failing experiments, our breakthrough came when we gave up using human material and went to the local slaughterhouse to purchase pig blood. Not a particular high-technological approach, but this transition from studying human blood to blood from a species with close homology had magic effects. After running into dead ends for two years and trying out the most complex gene-technological ways to produce the right material, it suddenly worked”, says Søren Kragh Moestrup, the head of the research group at Department of Biomedicine.

The discovery provides new essential information on haemoglobin that makes up most of the red cell interior. Haemoglobin is an essential blood component for transport of oxygen, but it becomes toxic with potential damaging effects on tissues, in particular the kidneys, when it is released from the red cells. An excessive release can occur in many diseases, such as malaria and other infections.

However, the body has a sophisticated defence system. The first line defence is carried out by the blood protein haptoglobin, which captures haemoglobin and gates it to a receptor that engulfs the haemoglobin-haptoglobin complex. This function of the receptor named CD163 was originally discovered by the same group.

“We have now shown how this unique protein complex forms by generation of a detailed 3-dimensional map of each atom. This shows for the first time how the complex is formed and explains the tight protein association”, says PhD Christian Brix Folsted Andersen. He has together with Master’s student Morten Torvund-Jensen been an essential driving force in the project.

The results have also led to an unexpected discovery of a novel type of protein structure and a new patent submission on exploitation of the discovery for use in generation of a new type of synthetic proteins to be used in therapy and diagnostics.

The Nature paper “Structure of the haptoglobin-haemoglobin complex” is available.

MEMBRANES is a research centre at Aarhus University with focus on membrane proteins.

The present international and interdisciplinary project has been headed by Department of Biomedicine, Aarhus University, with participation of Science & Technology, Aarhus University and experts from Brazil and Norway.

Financial support from The Lundbeck Foundation, The Novo Nordisk Foundation, The Research Council of Norway, The European Research Council and The Danish Council for Independent Research.

Contacts and sources:
Soeren Kragh Moestrup
Aarhus University